AFYREN SAS Reports Accelerated Industrial Ramp‑Up and Robust First‑Half Sales Growth

AFYREN SAS, the Paris‑listed greentech specialist that supplies biobased, low‑carbon ingredients to a range of sectors—including flavors, lubricants, feed, food, life sciences and materials science—announced on 16 June 2026 that it has achieved a significant milestone in its production ramp‑up. The company confirmed that sales in the first half of 2026 reached at least €1 million, a figure that doubles the comparable period in 2025. The jump is attributed to tangible progress in the industrial scale‑up of its fermentation facility in Clermont‑Ferrand, where the firm has demonstrated improved control and capacity utilisation.

Key Highlights from the June 2026 Annual General Meeting

  • Shareholder approvals: The 2026 Annual General Meeting, attended by 72.8 % of the company’s share capital, ratified all proposed resolutions by large margins. This decisive approval signals strong investor confidence in the company’s strategic direction and operational execution.
  • Positive analyst coverage: On 18 June, TP ICAP Midcap initiated coverage of AFYREN, issuing a positive recommendation. The analyst noted the firm’s unique circular fermentation model and its potential to capture a growing share of the low‑carbon market.

Market Impact

The announcement triggered a modest rally in AFYREN’s share price. As of the close on 16 June 2026, the stock traded at €2.88, down slightly from its 52‑week high of €3.235 (recorded on 30 November 2025) but well above the 52‑week low of €2.065 (27 April 2026). The market cap stood at €111 million, reflecting the market’s recognition of the company’s evolving production capabilities.

Forward‑Looking Outlook

The firm’s management emphasised that the second half of 2026 is expected to build on the current momentum, with production volumes poised to accelerate further. Given AFYREN’s focus on biobased alternatives to petroleum‑derived molecules, the company is positioned to benefit from increasing demand for sustainable ingredients across multiple high‑growth sectors.

In sum, AFYREN’s confirmed industrial ramp‑up and doubled first‑half sales represent a pivotal step toward commercialising its fermentation technology at scale, underpinning the company’s long‑term value proposition in the greentech arena.